Background: Patients with well-differentiated liposarcoma (WDLPS) of the extremity are mostly treated surgically, thereby possibly inducing severe morbidities. Despite the excellent prognosis, the natural history is barely studied. The aim of this study was to evaluate the natural history of extremity WDLPS by evaluating the outcome of patients treated with active surveillance (AS), who thereby exhibited the natural history of extremity WDLPS, and of patients treated surgically. Methods: A large retrospective database of patients with extremity WDLPS was assessed to evaluate treatment, dedifferentiation and disease-specific survival. Lastly, our experience with patients treated with AS was explored. Results: Distant metastases (5/191 patients, 2.6%) were mainly seen after a dedifferentiated local recurrence. Death of disease occurred in 4/191 patients (2.1%); two patients died from metastatic disease (although not pathologically proven), two patients died of treatment-related complications. In our center, 24 patients are treated with AS. Time of AS varied from 0.1 to 8.9 years (median 1.8). Four patients eventually underwent surgery after a period of AS (range 14–52 months) because of symptoms and/or tumor growth. No areas of dedifferentiation were found in these resection specimens. The other patients are still under active surveillance. Conclusion: Since surgical treatment might induce morbidity and even mortality, there might be overtreatment of these patients. Evaluation of the natural history of extremity WDLPS showed that AS could be a reasonable option for selected patients. Prospective studies in patients with extremity WDLPS are needed to assess the safety of AS as a treatment option.

, , , ,
doi.org/10.1016/j.suronc.2019.04.004, hdl.handle.net/1765/117778
Surgical Oncology: a review journal of cancer research & management
Department of Medical Microbiology and Infectious Diseases

Vos, M., Grunhagen, D. J., Kosela-Paterczyk, H, Rutkowski, P., Sleijfer, S., & Verhoef, K. (2019). Natural history of well-differentiated liposarcoma of the extremity compared to patients treated with surgery. Surgical Oncology: a review journal of cancer research & management, 29, 84–89. doi:10.1016/j.suronc.2019.04.004